Need professional-grade analysis? Visit stockanalysis.com
$31.27B
14.66
N/A
11.64%
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY40.70, down 1.09% from the previous close.
Over the past year, 600329 has traded between a low of CNY29.50 and a high of CNY50.05. The stock has gained 34.2% over this period. It is currently 18.7% below its 52-week high.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd has a market capitalization of $31.27B, with a price-to-earnings ratio of 14.66 and a dividend yield of 11.64%.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.